Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Patients
- DOI
- 10.1016/j.cllc.2025.01.014
- Published
- 2025-06
- Container
- Clinical Lung Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.cllc.2025.01.014,
title = {Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50\%) Patients},
author = {Adriana P.C. Barrichello and Arielle Elkrief and Biagio Ricciuti and Teja Ganta and Thomas U. Marron and Xinan Wang and William Lotter and James Lindsay and Valentina Santo and Alessio Cortellini and Bijaya Sharma and Kristen Felt and Kathleen Pfaff and Giuseppe Lamberti and Federica Pecci and Alessandro Di Federico and Maisam Makarem and Malini M. Gandhi and Tom Nguyen and Danielle Haradon and Victor R. Vaz and Bruce E. Johnson and Neha Debnath and Yinghong Wang and Andrew G. Kuang and Anwaar Saeed and Maluki Radford and Christine M. Lovly and Caroline A. Nebhan and David J. Pinato and Scott J. Rodig and Adam J. Schoenfeld and Mark M. Awad and Joao V. Alessi and Abdul Rafeh Naqash},
year = {2025},
journal = {Clinical Lung Cancer},
doi = {10.1016/j.cllc.2025.01.014},
url = {https://doi.org/10.1016/j.cllc.2025.01.014}
}RIS
TY - JOUR TI - Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Patients AU - Adriana P.C. Barrichello AU - Arielle Elkrief AU - Biagio Ricciuti AU - Teja Ganta AU - Thomas U. Marron AU - Xinan Wang AU - William Lotter AU - James Lindsay AU - Valentina Santo AU - Alessio Cortellini AU - Bijaya Sharma AU - Kristen Felt AU - Kathleen Pfaff AU - Giuseppe Lamberti AU - Federica Pecci AU - Alessandro Di Federico AU - Maisam Makarem AU - Malini M. Gandhi AU - Tom Nguyen AU - Danielle Haradon AU - Victor R. Vaz AU - Bruce E. Johnson AU - Neha Debnath AU - Yinghong Wang AU - Andrew G. Kuang AU - Anwaar Saeed AU - Maluki Radford AU - Christine M. Lovly AU - Caroline A. Nebhan AU - David J. Pinato AU - Scott J. Rodig AU - Adam J. Schoenfeld AU - Mark M. Awad AU - Joao V. Alessi AU - Abdul Rafeh Naqash PY - 2025 JO - Clinical Lung Cancer DO - 10.1016/j.cllc.2025.01.014 UR - https://doi.org/10.1016/j.cllc.2025.01.014 ER -
APA
Barrichello, A. P., Elkrief, A., Ricciuti, B., Ganta, T., Marron, T. U., Wang, X., Lotter, W., Lindsay, J., Santo, V., Cortellini, A., Sharma, B., Felt, K., Pfaff, K., Lamberti, G., Pecci, F., Federico, A. D., Makarem, M., Gandhi, M. M., Nguyen, T., Haradon, D., Vaz, V. R., Johnson, B. E., Debnath, N., Wang, Y., Kuang, A. G., Saeed, A., Radford, M., Lovly, C. M., Nebhan, C. A., Pinato, D. J., Rodig, S. J., Schoenfeld, A. J., Awad, M. M., Alessi, J. V., & Naqash, A. R. (2025). Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Patients. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2025.01.014
Source records
- crossref · retrieved 2026-09-25T22:42:39.342Z